ArticleCEN case reports2026
Pediatric case of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with immunoglobulin a deposition diagnosed early through school urinary screening.
Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a rare but severe condition in children, and renal involvement in the form of ANCA-associated glomerulonephritis (AAGN) usually determines prognosis. Although AAGN is characterized by pauci-immune necrotizing crescentic glomerulonephritis, mesangial immunoglobulin A (IgA) deposition occurs in a subset of patients; however, pediatric cases remain exceptionally rare. We aimed to report a case of a 12-year-old girl who was asymptomatic and diagnosed through routine school urinalysis. She presented with hematuria and progressive proteinuria, accompanied by elevated myeloperoxidase (MPO)-ANCA levels, while renal function was preserved. Renal biopsy revealed a cellular crescent with surrounding inflammatory cell infiltration, consistent with AAGN. Immunofluorescence microscopy demonstrated mesangial deposition of IgA, immunoglobulin M, and C3; however, there was no mesangial cell proliferation or matrix expansion to suggest typical IgA nephropathy. Based on the clinical course and pathological findings, the primary pathological process was considered to be AAGN rather than IgA nephropathy. The patient was treated with methylprednisolone pulse therapy, followed by rituximab and maintenance therapy with azathioprine. MPO-ANCA levels and proteinuria normalized, and no relapse has been observed. This case highlights the significance of early detection of pediatric renal-limited AAV and suggests that timely AAV-based immunosuppressive therapy promotes favorable outcomes in pediatric AAGN with IgA deposition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.